Patricia Grabowski: Difference between revisions

From MEpedia, a crowd-sourced encyclopedia of ME and CFS science and history
VisualWikitext
(added study)
Line 11: Line 11:
*2017, Serological profiling of the [[EBV]] immune response in [[Chronic Fatigue Syndrome]] using a peptide microarray<ref name="Loebel, 2017" /> [http://journals.plos.org/plosone/article/authors?id=10.1371/journal.pone.0179124 (Full Text)]
*2017, Serological profiling of the [[EBV]] immune response in [[Chronic Fatigue Syndrome]] using a peptide microarray<ref name="Loebel, 2017" /> [http://journals.plos.org/plosone/article/authors?id=10.1371/journal.pone.0179124 (Full Text)]
*2018, [[Immunoadsorption]] to remove ß2 adrenergic receptor antibodies in [[Chronic Fatigue Syndrome]] [[ME/CFS|CFS/ME]]<ref>{{Cite journal|last=Scheibenbogen|first=Carmen|author-link=Carmen Scheibenbogen|last2=Loebel|first2=Madlen|author-link2=Madlen Löbel|last3=Freitag|first3=Helma|author-link3=Helma Freitag|last4=Krueger|first4=Anne|last5=Bauer|first5=Sandra|last6=Antelmann|first6=Michaela|last7=Doehner|first7=Wolfram|last8=Scherbakov|first8=Nadja|last9=Heidecke|first9=Harald|last10=Reinke|first10=Petra|last11=Volk|first11=Hans-Dieter|last12=Grabowski|first12=Patricia|author-link12=Patricia Grabowski|date=2018|title=Immunoadsorption to remove ß2 adrenergic receptor antibodies in Chronic Fatigue Syndrome CFS/ME|url=http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0193672|journal=PLoS ONE|volume=13|issue=3|pages=e0193672|doi=10.1371/journal.pone.0193672|via=}}</ref> [http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0193672 (Full Text)]
*2018, [[Immunoadsorption]] to remove ß2 adrenergic receptor antibodies in [[Chronic Fatigue Syndrome]] [[ME/CFS|CFS/ME]]<ref>{{Cite journal|last=Scheibenbogen|first=Carmen|author-link=Carmen Scheibenbogen|last2=Loebel|first2=Madlen|author-link2=Madlen Löbel|last3=Freitag|first3=Helma|author-link3=Helma Freitag|last4=Krueger|first4=Anne|last5=Bauer|first5=Sandra|last6=Antelmann|first6=Michaela|last7=Doehner|first7=Wolfram|last8=Scherbakov|first8=Nadja|last9=Heidecke|first9=Harald|last10=Reinke|first10=Petra|last11=Volk|first11=Hans-Dieter|last12=Grabowski|first12=Patricia|author-link12=Patricia Grabowski|date=2018|title=Immunoadsorption to remove ß2 adrenergic receptor antibodies in Chronic Fatigue Syndrome CFS/ME|url=http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0193672|journal=PLoS ONE|volume=13|issue=3|pages=e0193672|doi=10.1371/journal.pone.0193672|via=}}</ref> [http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0193672 (Full Text)]
*2020, IgG stimulated β2 adrenergic receptor activation is attenuated in patients with ME/CFS<ref>https://doi.org/10.1016/j.bbih.2020.100047</ref> - [https://www.sciencedirect.com/science/article/pii/S2666354620300120 (Full text)]


==Talks and interviews==
==Talks and interviews==

Revision as of 16:52, April 3, 2020

Patricia Grabowski, PD Dr. med., is an associate in the immunodeficiency outpatient department, specializing in chronic fatigue syndrome and a specialist in internal medicine, specializing in hematology/oncology at Charité Universitätsmedizin Berlin, Germany. She's the group leader for the Patricia Grabowski's Lab at the Research Center ImmunoSciences, Charité Universitätsmedizin Berlin.[1]

EUROMENE[edit | edit source]

Dr. Grabowski is a substitute member of the Biomarkers Working Group of EUROMENE, a European Union, COST Action CA15111, not-for-profit research organization committed to tackling the cause and treatment for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.[2]

Notable studies[edit | edit source]


Talks and interviews[edit | edit source]

Online presence[edit | edit source]

Learn more[edit | edit source]

See also[edit | edit source]

References[edit | edit source]

  1. ↑ https://www.linkedin.com/in/patricia-grabowski-6163b072/
  2. ↑ http://www.cost.eu/COST_Actions/ca/CA15111?management
  3. ↑ Loebel, Madlen; Mooslechner, Agnes Anna; Bauer, Sandra; Günther, Sabrina; Letsch, Anne; Hanitsch, Leif G; Grabowski, Patricia; Meisel, Christian; Volk, Hans-Dieter; Scheibenbogen, Carmen (2015), "Polymorphism in COMT is associated with IgG3 subclass level and susceptibility to infection in patients with chronic fatigue syndrome", Journal of Translational Medicine, 13, doi:10.1186/s12967-015-0628-4
  4. ↑ Guenther, Sabrina; Loebel, Madlen; Mooslechner, Agnes A; Knops, Michael; Hanitsch, Leif G; Grabowski, Patricia; Wittke, Kirsten; Meisel, Christian; Unterwalder, Nadine; Volk, Hans-Dieter; Scheibenbogen, Carmen (2015), "Frequent IgG subclass and mannose binding lectin deficiency in patients with chronic fatigue syndrome", Human Immunology, 76 (10): 729-35, doi:10.1016/j.humimm.2015.09.028
  5. ↑ Loebel, M; Grabowski, P; Heidecke, H; Bauer, S; Hanitsch, LG; Wittke, K; Meisel, C; Reinke, P; Volk, H; Fluge, Ø; Mella, O; Scheibenbogen, C (2016), "Antibodies to β adrenergic and muscarinic cholinergic receptors in patients with Chronic Fatigue Syndrome", Brain, behavior, and immunity, 52: 32-39, doi:10.1016/j.bbi.2015.09.013
  6. ↑ Loebel, Madlen; Eckey, Maren; Sotzny, Franziska; Hahn, Elisabeth; Bauer, Sandra; Grabowski, Patricia; Zerweck, Johannes; Holenya, Pavlo; Hanitsch, Leif G.; Wittke, Kirsten; Borchmann, Peter; Rüffer, Jens-Ulrich; Hiepe, Falk; Ruprecht, Klemens; Behrends, Uta; Meindl, Carola; Volk, Hans-Dieter; Reimer, Ulf; Scheibenbogen, Carmen (2017), "Serological profiling of the EBV immune response in Chronic Fatigue Syndrome using a peptide microarray", PLOS ONE, 12 (6): e0179124, doi:10.1371/journal.pone.0179124
  7. ↑ Scheibenbogen, Carmen; Loebel, Madlen; Freitag, Helma; Krueger, Anne; Bauer, Sandra; Antelmann, Michaela; Doehner, Wolfram; Scherbakov, Nadja; Heidecke, Harald; Reinke, Petra; Volk, Hans-Dieter; Grabowski, Patricia (2018). "Immunoadsorption to remove ß2 adrenergic receptor antibodies in Chronic Fatigue Syndrome CFS/ME". PLoS ONE. 13 (3): e0193672. doi:10.1371/journal.pone.0193672.
  8. ↑ https://doi.org/10.1016/j.bbih.2020.100047

antibodies Antibody/immunoglobulin refers to any of a large number of specific proteins produced by B cells that act against an antigen in an immune response.

β β / Β. Greek letter beta (a symbol used in science), equivalent to "b".

cholinergic Involving the neurotransmitter acetylcholine. Cholinergic side effects include diarrhea, blurred vision, decreased intraocular pressure, contricted pupil in the eyes, sweating, increased saliva and mucus on the lungs, bronchial constriction, increased gastrointestinal tone, decreased blood pressure, slow heart rate, and contraction of bladder detrusor muscle. muscle spasms/cramps, low blood pressure, slowed heart rate, nausea and vomiting, increased saliva and sweating, shortness of breath, and urinating more often.

antibodies Antibody/immunoglobulin refers to any of a large number of specific proteins produced by B cells that act against an antigen in an immune response.

antibodies Antibody/immunoglobulin refers to any of a large number of specific proteins produced by B cells that act against an antigen in an immune response.

Retrieved from "https://me-pedia.org/w/index.php?title=Patricia_Grabowski&oldid=80790"